Tomographische Funktionsdiagnostik in der Nuklearmedizin

 

^* Herrn Prof. Dr. Helmut Rosier, Bern, zum 60. Geburtstag.

• LITERATUR

• 1 Bares R, Fass J, Truong S, Büll U, Schumpelick V. Radioimmunszintigraphie mit SPECT: Methodik, Probleme und klinische Erfahrungen. Nucl-Med 1987; 26: 202-5.
• 2 Baum R P, Lorenz M, Hottenrott C. et al. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125. Internat J Biol Markers 1988; 03: 177-84.
• 3 Biersack H J, Linke D, Breasscl F. et al. Technetium-99m HM-PAO brain SPECT in epileptic patients before and during unilateral hemispheric anesthesia (Wada-test): report of three cases. J Nucl Med 1987; 28: 1763-7.
• 4 Bolsa N M, Rajagopalan B, Mitsumori F, Radda G K. Metabolic changes during experimental cerebral ischemia in hyperglycemic rats, observed by ³¹P and ¹H magnetic resonance spectroscopy. Stroke 1988; 19: 608-14.
• 5 Braunwald E, Kloner R A. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1146-9.
• 6 Braunwald E, Rutherford J D. Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”. J Amer Coll Cardiol 1986; 08: 1467-70.
• 7 Bryant D J, Bydder G M, Case H A. et al. Use of phosphorus-31 MR spectroscopy to monitor response to chemotherapy in non- Hodgkin lymphoma. J Comp Ass Tomogr 1988; 12: 770-4.
• 8 Büll U. Positron versus single-photon ECT or PET complementing SPECT? What can be done with PET beyond research? Make PET go bedside!. Nucl-Mcd 1988; 27: 2-4.
• 9 Büll U, Braun H, Ferbert A. et al. Combined SPECT imaging of regional cerebral blood flow (^99mTc-HMPAO) and blood volume (^99mTc-RBC) to assess regional cerebral perfusion reserve in patients with cerebrovascular disease. Nucl-Med 1988; 27: 51-6.
• 10 Deusscn A, Borst M, Schradcr J. Formation of S-adenosylhomocystein in the heart. I. An index of free intracellular adenosine. Circulation Res 1988; 63: 240-9.
• 11 Deussen A, Borst M, Kroll K, Schrader J. Formation of S-adenosylhomocystein in the heart. II. A sensitive index for regional myocardial underperfusion. Circulation Res 1988; 63: 250-61.
• 12 Frackowiak R S. PET scanning: can it help resolve management issues in cerebral ischemic disorders?. Stroke 1986; 17: 803-7.
• 13 Franck G, Sadzot B, Salmon E. et al. Regional cerebral blood flow and metabolic rates in human focal epilepsy and status epilepticus. Adv Neurol 1986; 44: 935-48.
• 14 Gibbs J M, Wise R J S, Leenders K L, Jones T. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet 1984; i: 310-4.
• 15 Gomes A S, Lois J F, Drinkwater D C, Corday S R. Coronary artery bypass grafts: visualization with MR imaging. Radiology 1987; 162: 175-9.
• 16 Goodwin D A. Pharmacokinetics and antibodies. J Nucl Med 1987; 28: 1358-62.
• 17 Gould R G, Lipton M J, McNamara M T. et al. Measurement of regional myocardial blood flow in dogs by ultrafast CT. Invest Radiol 1988; 23: 348-53.
• 18 Hör G, Bussmann W D. Kardiovaskuläre Nuklearmedizin. Stuttgart - New York: Fischer; 1984
• 19 Hoffman J I E. Maximal coronary flow and the conccpt of coronary vascular reserve. Circulation 1984; 70: 153-9.
• 20 Kcycux A, Latcrrc Ch, Beckers Ch. Resting and hyperkapnic rCBF in patients with unilateral occlusive disease of the internal carotid artery. J Nucl Med 1988; 29: 311-9.
• 21 Knapp W H, Kummer R, Kühler W. Imaging of cerebral blood flow-to-volume distribution using SPECT. J Nucl Med 1986; 27: 465-70.
• 22 Krestin G P, Steinbrich W, Friedmann G. Recurrent rectal cancer: diagnosis with MIR imaging versus CT. Radiology 1988; 168: 307-11.
• 23 Kuhl D. Imaging of local brain function with ECT. Radiology 1984; 150: 625-31.
• 24 Kummer R, Scharf J, Back T. et al. Autoregulatory capacity and the effect of isovolumic hemodilution on local cercbral blood flow. Stroke 1988; 19: 594-7.
• 25 Leinsingcr G, Schmiedck P, Kreisig T. et al. ¹³³Xe-DPECT: Bedeutung der zerebrovaskulären Reservekapazität für Diagnostik und Therapie der chronischen zerebralen Ischämic. Nucl-Med 1988; 27: 127-34.
• 26 Levine R L, Sunderland J J, Lagreze H L ct al. Cerebral perfusion reserve indexes determined by fluoromethane PET. Stroke 1988; 19: 19-27.
• 27 Linden A, Smolorz J, Deutsch H. et al. Visualization of coronary arteries and coronary bypass grafts by nuclear magnetic resonance. In: Schmidt H A E, Czcrnay L. Hrsg. Nuklearmedizin. Stuttgart - New York: Schattauer; 1988: 118-21.
• 28 Metter E J, Wasterlain C G, Kuhl D E, Hanson W R, Phelps M E. ¹⁸FDG-PET in a study of aphasia. Ann Neurol 1981; 10: 173-83.
• 29 Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with ¹⁸F-FDG. J Nucl Med 1988; 29: 1521-5.
• 30 Nissen St E, Elion J L, Booth D C, Evans J, DeMaria A N. Value and limitations of computer analysis of digital subtraction angiography in the assessment of coronary flow reserve. Circulation 1986; 73: 562-71.
• 31 Powers W J, Raichle M E. PET and its application to the study of cerebrovascular disease in man. Stroke 1985; 16: 361-76.
• 32 Reske S N. Radiopharmakologische Grundlagen und klinische Aussagekraft der Myokardszintigraphie mit ¹²³J-markicrten Fettsäuren. Nucl-Med 1987; 26: 123-8.
• 33 Ringelstein E B, Sievers C, Ecker S, Schneider P A, Otis S M. Noninvasive assessment of CO₂-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusion. Stroke 1988; 19: 963-9.
• 34 Rozanski A, Berman D S. Silent myocardial ischemia. II. Prognosis and implications for the clinical assessment of patients with coronary artery disease. Am Heart J 1987; 114: 627-38.
• 35 Rubinstein R I, Askenase A D, Thickman D. et al. Magnetic resonance imaging to evaluate patcncy of aortocoronary bypass. Circulation 1987; 76: 786-91.
• 36 Sakai F, Nakazawa K, Tazaki Y. Regional cerebral blood volume and hematocrit measured in normal human volunteers by SPECT. J Ccrebr Blood Flow Mctab 1985; 05: 207-13.
• 37 Samson Y, Baron J C, Bousscr M G ct al. Effects of extra-intracranial arterial bypass on cerebral blood flow and oxygen metabolism in humans. Stroke 1985; 16: 609-16.
• 38 Schelbert H. Current status and prospects of new radionuclides and radiopharmaccuticals for cardiovascular nuclear medicine. Sem Nucl Med 1987; 17: 145-81.
• 39 Schelbert H, Buxton D. Insights into coronary artery disease gained from metabolic imaging. Circulation 1988; 78: 496-505.
• 40 Schicha H. Nuklcarmedizinische Diagnostik in der Kardiologie. Internist Welt 1986; 08: 31-41.
• 41 Schmidt U, Knapp W H, Busse O. et al. Veränderung der zerebralen Aufnahme von ^99mTc-HMPAO in Abhängigkeit vom arteriellen CO₂-Spiegel. Nucl-Med 1988; 27 (02) 27.
• 42 Schmid-Schönbein H, Rieger H. Why hemo- dilution in low flow states?. Biblth haemat 1981; 47: 99-121.
• 43 Stirncr H, Büll U, Kleinhans E, Bares R, Grosse W. Myocardial kinetics of ^99mTc- HM1B1 in patients with coronary heart disease versus ²⁰¹T1 with SPECT. Nucl Med Comm 1988; 09: 15-23.
• 44 Strauer B E. Koronare Mikrozirkulationsstörungen. Klin Wschr 1981; 59: 1125-37.
• 45 Strauer B E, Büll U, Bürger S. Clinical and experimental analysis of ²⁰¹TI uptake of the heart. Nucl-Med 1978; 17: 142-8.
• 46 Strauss L G, Chlorius J H. Tumor diagnosis and therapy follow-up with PET. Tumor- diagn Ther 1988; 09: 171-2.
• 47 Unger E C, Otty W G, Neufeld D M. et al. Magnetic resonance imaging using gadolinium-labeled monoclonal antibody. Invest Radiol 1985; 20: 693-700.
• 48 Vyska K, Machulla H J, Stremmel W. et al. Regional myocardial free fatty acid extraction in normal and ischemic myocardium. Circulation 1988; 70: 1218-33.
• 49 Young I R, Hall A S, Bryant D J. et al. Assessment of brain perfusion with MR imaging. J Comp Ass Tomogr 1988; 12: 721-7.